Skip to main content
TipRanks
Go Ultimate75% OFF

Urogen Pharma (0XOD) Income Statement

1 Followers

Urogen Pharma Income Statement

Last quarter (Q3 2026), Urogen Pharma's total revenue was $89.00M, an increase of 223.85% from the same quarter last year. In Q3, Urogen Pharma's net income was $-1.46M. See Urogen Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 109.79M$ 90.40M$ 82.71M$ 64.36M$ 48.04M
$ 97.34M$ 81.52M$ 73.35M$ 56.70M$ 42.88M
$ 222.20M$ 178.30M$ 138.89M$ 135.74M$ 135.18M
Depreciation and Amortization$ 2.41M$ 1.19M$ 1.71M$ 1.82M$ 1.77M
$ -135.66M$ -94.50M$ -60.35M$ -76.21M$ -107.60M
$ -124.86M$ -96.78M$ -65.54M$ -79.04M$ -92.29M
$ -28.55M$ -27.26M$ -32.79M$ -28.99M$ -17.08M
$ -153.42M$ -124.04M$ -98.32M$ -108.03M$ -109.37M
$ -153.49M$ -126.87M$ -102.24M$ -109.78M$ -110.82M
Per Share Metrics
Basic EPS$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Diluted EPS$ -3.19$ -2.96$ -3.55$ -4.79$ -4.96
Weighted Average Shares Outstanding48.12M42.88M28.83M22.81M22.35M
Weighted Average Shares Outstanding (Diluted)48.12M42.88M28.83M22.81M22.35M

Currency in USD

Urogen Pharma Earnings and Revenue History

-300M-150M0150M-750000 %-500000 %-250000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin